Arcus Biosciences RCUS 深 滬
等待開盤 09-11 09:30:00 美东时间
11.72
+0.400
+3.53%
華盛通- 最 高11.81
- 今 開11.33
- 成交量 88.83万股
- 最 低 11.16
- 昨 收 11.32
- 總市值 12.42亿
- 52周最高 18.98
- 市盈率 靜 --
- 換手率 0.84%
- 52周最低 6.50
- 委 比 -77.78%
- 總股本 1.06亿
- 歷史最高 49.10
- 量 比 0.85
- 振 幅 5.74%
- 歷史最低 6.30
- 每 手 1
- 風險率 1.46%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were mixed, with the Dow Jones index falling over 150 points on Wed...
09-03 22:10
跨国药企洞察｜罗氏加码“减肥药物”500亿美元项目部分破土动工 多项早期管线“瘦身”
（来源：动脉新医药） 编者按： 全球视野下的跨国药企深度洞察——创新、博弈与中国答卷 在全球医药产业发展的宏大叙事中，跨国药企始终扮演着关键角色——他们...
08-27 18:33
Gilead Sciences Lifts Annual Outlook As Yeztugo Launch Nears
Gilead raised its 2025 earnings and sales outlook after posting better-than-expected Q2 results, led by strong HIV and oncology drug sales.
08-08 22:55
Wells Fargo Maintains Overweight on Arcus Biosciences, Lowers Price Target to $25
Wells Fargo analyst Eva Fortea Verdejo maintains Arcus Biosciences (NYSE:RCUS) with a Overweight and lowers the price target from $26 to $25.
08-07 22:43
Earnings Scheduled For August 6, 2025
Companies Reporting Before The Bell • Lineage (NASDAQ:LINE) is likely to report...
08-06 16:33
Gilead and Arcus Advance Immunotherapy Study in Lung Cancer
Gilead Sciences (($GILD)), Arcus Biosciences (($RCUS)), Gilead Sciences (($CC:G...
08-02 00:23
Arcus Biosciences Advances Cancer Treatment with AB801 Study
Arcus Biosciences (($RCUS)) announced an update on their ongoing clinical study...
08-02 00:22
Gilead and Arcus Biosciences’ Promising Lung Cancer Study: Market Implications
Gilead Sciences (($GILD)), Arcus Biosciences (($RCUS)), Gilead Sciences (($CC:G...
07-25 00:29
Arcus Biosciences’ cancer drug gets orphan drug status
Arcus Biosciences (NYSE:RCUS) said on Thursday that its experimental drug candidate, quemliclustat, has received orphan drug status from the U.S. FDA. Quemliclustat is a type of medication that works ...
07-10 22:24
Arcus Biosciences Presents Promising Phase 1/1b Trial Data
Arcus Biosciences ( ($RCUS) ) has provided an update. On June 1, 2025, Arcus Bi...
06-02 20:45
